-
公开(公告)号:US09260502B2
公开(公告)日:2016-02-16
申请号:US12922106
申请日:2009-03-13
申请人: Peter Kresten Nielsen , Frantisek Hubalek , Inger Lautrup-Larsen , Per Balschmidt , Svend Ludvigsen , Thomas Børglum Kjeldsen
发明人: Peter Kresten Nielsen , Frantisek Hubalek , Inger Lautrup-Larsen , Per Balschmidt , Svend Ludvigsen , Thomas Børglum Kjeldsen
摘要: The present invention relates to novel insulin analogs comprising mutations at position A14 in the A chain and at positions B27, B28, B29 and B30 in the B chain and exhibiting resistance towards protease; a method for the preparation of such insulin analogs; insulin preparations containing the insulin analogs of the invention; and, a method of treating diabetes mellitus using these insulin analogs.
摘要翻译: 本发明涉及新的胰岛素类似物,其包含A链A14位和B链位置B27,B28,B29和B30处的突变,并表现出对蛋白酶的抗性; 一种制备这种胰岛素类似物的方法; 含有本发明胰岛素类似物的胰岛素制剂; 以及使用这些胰岛素类似物治疗糖尿病的方法。
-
公开(公告)号:US20110092419A1
公开(公告)日:2011-04-21
申请号:US12922106
申请日:2009-03-19
申请人: Peter Kresten Nielsen , Frantisek Hubalek , Inger Lautrup-Larsen , Per Balschmidt , Svend Ludvigsen , Thomas Børglum Kjeldsen
发明人: Peter Kresten Nielsen , Frantisek Hubalek , Inger Lautrup-Larsen , Per Balschmidt , Svend Ludvigsen , Thomas Børglum Kjeldsen
摘要: The present invention relates to novel insulin analogues comprising mutations at position A14 in the A chain and at positions B27, B28, B29 and B30 in the B chain and exhibiting resistance towards protease; a method for the preparation of such insulin analogues; insulin preparations containing the insulin analogues of the invention; and, a method of treating diabetes mellitus using these insulin analogues.
摘要翻译: 本发明涉及新的胰岛素类似物,其包含A链A14位和B链位置B27,B28,B29和B30的突变,并表现出对蛋白酶的抗性; 一种制备这种胰岛素类似物的方法; 含有本发明胰岛素类似物的胰岛素制剂; 以及使用这些胰岛素类似物治疗糖尿病的方法。
-
公开(公告)号:US09018161B2
公开(公告)日:2015-04-28
申请号:US12442190
申请日:2007-09-20
申请人: Peter Kresten Nielsen , Frantisek Hubalek , Inger Lautrup-Larsen , Svend Ludvigsen , Ulla Ribel-Madsen , Per Balschmidt , Per Nørgaard , Svend Havelund
发明人: Peter Kresten Nielsen , Frantisek Hubalek , Inger Lautrup-Larsen , Svend Ludvigsen , Ulla Ribel-Madsen , Per Balschmidt , Per Nørgaard , Svend Havelund
摘要: The present invention relates to novel insulin analogues exhibiting resistance towards protease, wherein at least two amino acids are substituted and/or deleted relative to the parent insulin molecule. A method for the preparation of such insulin analogues, insulin preparations containing the insulin analogues of the invention and a method of treating diabetes mellitus using these insulin analogues is also provided.
摘要翻译: 本发明涉及对蛋白酶表现出抗性的新型胰岛素类似物,其中至少两个氨基酸相对于母体胰岛素分子被取代和/或缺失。 还提供了制备这种胰岛素类似物的方法,含有本发明的胰岛素类似物的胰岛素制剂和使用这些胰岛素类似物治疗糖尿病的方法。
-
公开(公告)号:US20100009898A1
公开(公告)日:2010-01-14
申请号:US12442190
申请日:2007-09-20
申请人: Peter Kresten Nielsen , Frantisek Hubalek , Inger Lautrup-Larsen , Svend Ludvigsen , Ulla Ribel-Madsen , Per Balschmidt , Per Norgaard , Svend Havelund
发明人: Peter Kresten Nielsen , Frantisek Hubalek , Inger Lautrup-Larsen , Svend Ludvigsen , Ulla Ribel-Madsen , Per Balschmidt , Per Norgaard , Svend Havelund
摘要: The present invention relates to novel insulin analogues exhibiting resistance towards protease, wherein at least two amino acids are substituted and/or deleted relative to the parent insulin molecule. A method for the preparation of such insulin analogues, insulin preparations containing the insulin analogues of the invention and a method of treating diabetes mellitus using these insulin analogues is also provided.
摘要翻译: 本发明涉及对蛋白酶表现出抗性的新型胰岛素类似物,其中至少两个氨基酸相对于母体胰岛素分子被取代和/或缺失。 还提供了制备这种胰岛素类似物的方法,含有本发明的胰岛素类似物的胰岛素制剂和使用这些胰岛素类似物治疗糖尿病的方法。
-
5.
公开(公告)号:US09120871B2
公开(公告)日:2015-09-01
申请号:US13522804
申请日:2011-01-20
申请人: Rita Slaaby , Inger Lautrup-Larsen
发明人: Rita Slaaby , Inger Lautrup-Larsen
摘要: Expression of FGF21 in a S. cerevisiae pmt2 knock out strain reduces the O-glycosylation significantly and does not decrease the expression level. Expression in mkc7 knock out strain can decrease degradation of FGF21 and analogues thereof. Point mutations at position R17 and R36 can decrease degradation of FGF21 and analogues thereof when they are expressed in yeast.
摘要翻译: FGF21在酿酒酵母pmt2敲除菌株中的表达显着降低了O-糖基化,并且不降低表达水平。 在mkc7敲除菌株中的表达可以降低FGF21及其类似物的降解。 R17和R36位点的突变可以在酵母中表达时降低FGF21的降解及其类似物。
-
公开(公告)号:US20130005951A1
公开(公告)日:2013-01-03
申请号:US13522804
申请日:2011-01-20
申请人: Rita Slaaby , Inger Lautrup-Larsen
发明人: Rita Slaaby , Inger Lautrup-Larsen
摘要: Expression of FGF21 in a S. cerevisiae pmt2 knock out strain reduces the O-glycosylation significantly and does not decrease the expression level. Expression in mkc7 knock out strain can decrease degradation of FGF21 and analogues thereof. Point mutations at position R17 and R36 can decrease degradation of FGF21 and analogues thereof when they are expressed in yeast.
摘要翻译: FGF21在酿酒酵母pmt2敲除菌株中的表达显着降低了O-糖基化,并且不降低表达水平。 在mkc7敲除菌株中的表达可以降低FGF21及其类似物的降解。 R17和R36位点的突变可以在酵母中表达时降低FGF21的降解及其类似物。
-
公开(公告)号:US20120282653A1
公开(公告)日:2012-11-08
申请号:US13510363
申请日:2010-11-25
IPC分类号: C12P21/00
CPC分类号: C07K14/575 , C12N9/60 , C12N15/81 , C12P21/02
摘要: The invention provides an improved method for producing polypeptides with a C-terminal glycine in a yeast transformant being characterized in having a non functional KEX1 gene. The method is in particular well suited to produce polypeptides with an aromatic amino acid residue attached to the C-terminal glycine. The yeast strain may have further non-functional protease genes selected from PEP4, YPS1, MKCI, YPS3, YPS5, YPS6, YPS7, PRB1, STE13 and KEX2.
摘要翻译: 本发明提供在酵母转化体中产生具有C-末端甘氨酸的多肽的改进方法,其特征在于具有非功能性KEX1基因。 该方法特别适用于产生具有连接至C-末端甘氨酸的芳族氨基酸残基的多肽。 酵母菌株可以具有选自PEP4,YPS1,MKCI,YPS3,YPS5,YPS6,YPS7,PRB1,STE13和KEX2的其他非功能性蛋白酶基因。
-
公开(公告)号:US08815541B2
公开(公告)日:2014-08-26
申请号:US13510363
申请日:2010-11-25
IPC分类号: C12P21/06 , C07K14/575 , C12P21/02 , C12N15/81 , C12N9/60
CPC分类号: C07K14/575 , C12N9/60 , C12N15/81 , C12P21/02
摘要: The invention provides an improved method for producing polypeptides with a C-terminal glycine in a yeast transformant being characterized in having a non functional KEX1 gene. The method is in particular well suited to produce polypeptides with an aromatic amino acid residue attached to the C-terminal glycine. The yeast strain may have further non-functional protease genes selected from PEP4, YPS1, MKCI, YPS3, YPS5, YPS6, YPS7, PRB1, STE13 and KEX2.
摘要翻译: 本发明提供在酵母转化体中产生具有C-末端甘氨酸的多肽的改进方法,其特征在于具有非功能性KEX1基因。 该方法特别适用于产生具有连接至C-末端甘氨酸的芳族氨基酸残基的多肽。 酵母菌株可以具有选自PEP4,YPS1,MKCI,YPS3,YPS5,YPS6,YPS7,PRB1,STE13和KEX2的其他非功能性蛋白酶基因。
-
-
-
-
-
-
-